Tag: Eczema management

Opzelura (ruxolitinib) is the first FDA-approved topical Janus kinase (JAK) inhibitor for both atopic dermatitis and vitiligo, but the recommended treatment duration varies significantly by condition. For atopic dermatitis, use is typically short-term and intermittent for flare-ups, while vitiligo treatment often requires continuous application over a much longer period.

Featuring a powerful combination of five active ingredients, K5 Derm cream is formulated to combat complex skin infections involving both bacterial and fungal pathogens, effectively relieving symptoms of inflammation and irritation. This multi-action formula addresses a wide spectrum of dermatological issues, making it a versatile prescription medication.